abstract |
The invention discloses a heterocyclic naphthalimide derivative, namely, a compound as shown in a formula (I). The heterocyclic naphthalimide derivative has good tumor resisting activity, and the various groups of the heterocyclic naphthalimide derivative are defined in the specification. In addition, the invention also discloses a preparation method of the derivative and a pharmaceutical composition containing the derivative. |